87
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Arsenic: an emerging role in adipose tissue dysfunction and muscle toxicity

, , , & ORCID Icon
Pages 1333-1342 | Received 01 Oct 2021, Accepted 07 Oct 2021, Published online: 23 Oct 2021

References

  • Ahmed, S., et al., 2011. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environmental health perspectives, 119 (2), 258–264.
  • Ali, A., Hochfeld, W., and Myburgh, R., 2013. Adipocyte and adipogenesis [J/OL]. European journal of cell biology, 92 (6), 1–14.
  • Ambrosio, F., et al., 2014. Arsenic induces sustained impairment of skeletal muscle and muscle progenitor cell ultrastructure and bioenergetics. Free radical biology & medicine, 74, 64–73.
  • Bae, J., et al., 2019. Arsenite exposure suppresses adipogenesis, mitochondrial biogenesis and thermogenesis via autophagy inhibition in brown adipose tissue. Scientific reports, 9 (1), 14.
  • Barringer, J.L. and Reilly, P.A., 2013. Arsenic in groundwater: a summary of sources and the biogeochemical and hydrogeologic factors affecting arsenic occurrence and mobility. Current perspectives in contaminant hydrology and water resources sustainability, 34, 83–116.
  • Bazuine, M., et al., 2003. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. European journal of biochemistry, 270 (19), 3891–3903.
  • Bodwell, J.E., Kingsley, L.A., and Hamilton, J.W., 2004. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chemical research in toxicology, 17 (8), 1064–1076.
  • Burnichon, V., et al., 2003. Patterns of gene expressions induced by arsenic trioxide in cultured human fibroblasts. Toxicology letters, 143 (2), 155–162.
  • Carlson, P., and Van Beneden, R.J., 2014. Arsenic exposure alters expression of cell cycle and lipid metabolism genes in the liver of adult zebrafish (Danio rerio). Aquatic toxicology, 153, 66–72.
  • Ceja-Galicia, Z.A., et al., 2017. Effects of arsenic on adipocyte metabolism: is arsenic an obesogen? Molecular and cellular endocrinology, 452, 25–32.
  • Choe, S.S., et al., 2016. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Frontiers in endocrinology, 7, 30.
  • De Castro, M.R., et al., 2009. Behavioral and neurotoxic effects of arsenic exposure in zebrafish (Danio rerio, Teleostei: Cyprinidae). Comparative biochemistry and physiology part C: toxicology & pharmacology, 150 (3), 337–342.
  • Ditzel, E.J., et al., 2016. Effects of arsenite exposure during fetal development on energy metabolism and susceptibility to diet-induced fatty liver disease in male mice. Environmental health perspectives, 124 (2), 201–209.
  • Doza, Y.N., Hall-Jackson, C.A., and Cohen, P., 1998. Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of Grb2-Sos. Oncogene, 17 (1), 19–24.
  • Du, S., et al., 2020. Arsenic in the pathway to cardiovascular diseases: arsenic may mediate lipid profile in adults. Current developments in nutrition, 4 (Supplement_2), 1630–1630.
  • Fantuzzi, G., 2005. Adipose tissue, adipokines, and inflammation. The journal of allergy and clinical immunology, 115 (5), 911–919.
  • Fantuzzi, G., 2014. Health versus disease as the catalyst for biomedical research: the science of adipokines as a case in point. Frontiers in endocrinology, 5, 136.
  • Frühbeck, G. and Gómez-Ambrosi, J., 2013. Adipose tissue: structure, function and metabolism. Encyclopedia of human nutrition, 1, 1-13.
  • Garciafigueroa, D.Y., et al., 2013. Arsenic-stimulated lipolysis and adipose remodeling is mediated by G-protein-coupled receptors. Toxicological sciences, 134 (2), 335–344.
  • Hays, A.M., et al., 2008. Arsenic-induced decreases in the vascular matrix. Toxicologic pathology, 36 (6), 805–817.
  • Henriques, F., Bedard, A.H., and Luiz Batista, M. Jr. 2019. Adipose tissue inflammation and metabolic disorders. Adipose tissue update, 1, 1–11.
  • Hopenhayn, C., et al., 2003. Arsenic exposure from drinking water and birth weight. Epidemiology, 14 (5), 593–602.
  • Hou, Y., et al., 2013. Association between arsenic suppression of adipogenesis and induction of CHOP10 via the endoplasmic reticulum stress response. Environmental health perspectives, 121 (2), 237–243.
  • Hu, Y., Jin, X., and Snow, E.T., 2002. Effect of arsenic on transcription factor AP-1 and NF-κB DNA binding activity and related gene expression. Toxicology letters, 133 (1), 33–45.
  • Hughes, M.F., et al., 2011. Arsenic exposure and toxicology: a historical perspective. Toxicological sciences, 123 (2), 305–332.
  • Huyck, K.L., et al., 2007. Maternal arsenic exposure associated with low birth weight in Bangladesh. Journal of occupational and environmental medicine, 49 (10), 1097–1104.
  • Jaishankar, M., et al., 2014. Toxicity, mechanism and health effects of some heavy metals. Interdisciplinary toxicology, 7 (2), 60–72.
  • Klei, L.R., Garciafigueroa, D.Y., and Barchowsky, A., 2013. Arsenic activates endothelin-1 Gi protein-coupled receptor signaling to inhibit stem cell differentiation in adipogenesis. Toxicological sciences, 131 (2), 512–520.
  • Lassar, A.B., Skapek, S.X., and Novitch, B., 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Current opinion in cell biology, 6 (6), 788–794.
  • Ledda, C., et al., 2018. Serum lipid, lipoprotein and apolipoprotein profiles in workers exposed to low arsenic levels: lipid profiles and occupational arsenic exposure. Toxicology letters, 282, 49–56.
  • Mazumder, D.G., 2008. Chronic arsenic toxicity & human health. Indian journal of medical research, 128, 436–447.
  • Muthumani, M., 2013. Silibinin attenuates arsenic induced alterations in serum and hepatic lipid profiles in rats. Journal of applied pharmaceutical science, 3, 132.
  • Oh, R.S., et al., 2012. Functional RNA interference (RNAi) screen identifies system A neutral amino acid transporter 2 (SNAT2) as a mediator of arsenic-induced endoplasmic reticulum stress. The journal of biological chemistry, 287 (8), 6025–6034.
  • Olson, E.N., Perry, M., and Schulz, R.A., 1995. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Developmental biology, 172 (1), 2–14.
  • Oyadomari, S. and Mori, M., 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell death and differentiation, 11 (4), 381–389.
  • Padmaja Divya, S., et al., 2015. Arsenic induces insulin resistance in mouse adipocytes and myotubes via oxidative stress-regulated mitochondrial Sirt3-FOXO3a signaling pathway. Toxicological sciences, 146 (2), 290–300.
  • Parvez, F., et al., 2011. Arsenic exposure and motor function among children in Bangladesh. Environmental health perspectives, 119 (11), 1665–1670.
  • Paul, D.S., et al., 2007a. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environmental health perspectives, 115 (5), 734–742.
  • Paul, D.S., et al., 2007b. Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicology and applied pharmacology, 222 (3), 305–314.
  • Recinella, L., et al., 2020. Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Frontiers in physiology, 11, 578966.
  • Renu, K., et al., 2021. Molecular mechanism of heavy metals (lead, chromium, arsenic, mercury, nickel and cadmium) induced hepatotoxicity–a review. Chemosphere, 271, 129735.
  • Renu, K., et al., 2018. Role of arsenic exposure in adipose tissue dysfunction and its possible implication in diabetes pathophysiology. Toxicology letters, 284, 86–95.
  • Renu, K., et al., 2020. An appraisal on molecular and biochemical signalling cascades during arsenic-induced hepatotoxicity. Life sciences, 260, 118438.
  • Rivas-Santiago, C., et al., 2019. Lipid metabolism alterations in a rat model of chronic and intergenerational exposure to arsenic. Biomed research international, 2019, 1–17.
  • Saggese, G., Fanos, M., and Simi, F., 2013. SGA children: auxological and metabolic outcomes–the role of GH treatment. The journal of maternal-fetal & neonatal medicine, 26 (sup2), 64–67.
  • Saha, J., et al., 1999. A review of arsenic poisoning and its effects on human health. Critical reviews in environmental science and technology, 29 (3), 281–313.
  • Schoettl, T., Fischer, I.P., and Ussar, S., 2018. Heterogeneity of adipose tissue in development and metabolic function. Journal of experimental biology, 221 (Suppl_1), jeb162958.
  • Singh, N., Kumar, D., and Sahu, A.P., 2007. Arsenic in the environment: effects on human health and possible prevention. Journal of environmental biology, 28 (2 Suppl), 359–365.
  • Trouba, K.J., Wauson, E.M., and Vorce, R.L., 2000. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicology and applied pharmacology, 164 (2), 161–170.
  • Tseng, C.-H., 2004. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicology and applied pharmacology, 197 (2), 67–83.
  • Tyler, C.R., and Allan, A.M., 2014. The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Current environmental health reports, 1, 132–147.
  • Walton, F.S., et al., 2004. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicology and applied pharmacology, 198 (3), 424–433.
  • Wang, Z.X., et al., 2005. The role of Akt on arsenic trioxide suppression of 3T3-L1 preadipocyte differentiation. Cell research, 15 (5), 379–386.
  • Wani, A.L., Ara, A., and Usmani, J.A., 2015. Lead toxicity: a review. Interdisciplinary toxicology, 8 (2), 55–64.
  • Wauson, E.M., Langan, A.S., and Vorce, R.L., 2002. Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicological sciences, 65 (2), 211–219.
  • Weintraub, H., 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell, 75 (7), 1241–1244.
  • Yen, Y.-P., et al., 2010. Arsenic inhibits myogenic differentiation and muscle regeneration. Environmental health perspectives, 118 (7), 949–956.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.